| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | acetyl-CoA carboxylase activity | 9.53e-07 | 2 | 20 | 2 | GO:0003989 | |
| GeneOntologyMolecularFunction | CoA carboxylase activity | 1.43e-05 | 6 | 20 | 2 | GO:0016421 | |
| GeneOntologyMolecularFunction | biotin binding | 1.43e-05 | 6 | 20 | 2 | GO:0009374 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-carbon bonds | 2.00e-05 | 7 | 20 | 2 | GO:0016885 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 2.16e-03 | 566 | 20 | 4 | GO:0001216 | |
| GeneOntologyBiologicalProcess | malonyl-CoA biosynthetic process | 6.39e-07 | 2 | 17 | 2 | GO:2001295 | |
| GeneOntologyBiologicalProcess | malonyl-CoA metabolic process | 9.57e-06 | 6 | 17 | 2 | GO:2001293 | |
| Domain | AcCoA_COase_cen | 1.09e-06 | 2 | 20 | 2 | IPR013537 | |
| Domain | ACC_central | 1.09e-06 | 2 | 20 | 2 | PF08326 | |
| Domain | Carboxyl_trans | 6.53e-06 | 4 | 20 | 2 | PF01039 | |
| Domain | COA_CT_N | 6.53e-06 | 4 | 20 | 2 | IPR011762 | |
| Domain | COA_CT_C | 6.53e-06 | 4 | 20 | 2 | IPR011763 | |
| Domain | COA_CT_CTER | 6.53e-06 | 4 | 20 | 2 | PS50989 | |
| Domain | Carboxyl_trans | 6.53e-06 | 4 | 20 | 2 | IPR000022 | |
| Domain | COA_CT_NTER | 6.53e-06 | 4 | 20 | 2 | PS50980 | |
| Domain | Biotin_COase_C | 1.09e-05 | 5 | 20 | 2 | IPR005482 | |
| Domain | Biotin_BS | 1.09e-05 | 5 | 20 | 2 | IPR001882 | |
| Domain | Biotin_carb_C | 1.09e-05 | 5 | 20 | 2 | SM00878 | |
| Domain | Biotin_carb_C | 1.09e-05 | 5 | 20 | 2 | PF02785 | |
| Domain | Biotin_carboxylation_dom | 1.09e-05 | 5 | 20 | 2 | IPR011764 | |
| Domain | BIOTIN | 1.09e-05 | 5 | 20 | 2 | PS00188 | |
| Domain | CPSASE_1 | 1.09e-05 | 5 | 20 | 2 | PS00866 | |
| Domain | BC | 1.09e-05 | 5 | 20 | 2 | PS50979 | |
| Domain | Rudment_hybrid_motif | 1.63e-05 | 6 | 20 | 2 | IPR011054 | |
| Domain | CPSASE_2 | 1.63e-05 | 6 | 20 | 2 | PS00867 | |
| Domain | CbamoylP_synth_lsu-like_ATP-bd | 2.28e-05 | 7 | 20 | 2 | IPR005479 | |
| Domain | BC-like_N | 2.28e-05 | 7 | 20 | 2 | IPR005481 | |
| Domain | Biotin_carb_N | 2.28e-05 | 7 | 20 | 2 | PF00289 | |
| Domain | CPSase_L_D2 | 2.28e-05 | 7 | 20 | 2 | PF02786 | |
| Domain | Biotin_lipoyl | 3.90e-05 | 9 | 20 | 2 | PF00364 | |
| Domain | Biotin_lipoyl | 4.88e-05 | 10 | 20 | 2 | IPR000089 | |
| Domain | BIOTINYL_LIPOYL | 4.88e-05 | 10 | 20 | 2 | PS50968 | |
| Domain | Single_hybrid_motif | 7.14e-05 | 12 | 20 | 2 | IPR011053 | |
| Domain | - | 8.44e-05 | 13 | 20 | 2 | 3.40.50.20 | |
| Domain | ATP-grasp | 9.84e-05 | 14 | 20 | 2 | IPR011761 | |
| Domain | PreATP-grasp_dom | 9.84e-05 | 14 | 20 | 2 | IPR016185 | |
| Domain | ATP_GRASP | 9.84e-05 | 14 | 20 | 2 | PS50975 | |
| Domain | - | 1.13e-04 | 15 | 20 | 2 | 3.30.1490.20 | |
| Domain | - | 1.65e-04 | 18 | 20 | 2 | 3.30.470.20 | |
| Domain | ATP_grasp_subdomain_1 | 1.65e-04 | 18 | 20 | 2 | IPR013815 | |
| Domain | - | 2.26e-04 | 21 | 20 | 2 | 3.90.226.10 | |
| Domain | ClpP/crotonase-like_dom | 2.26e-04 | 21 | 20 | 2 | IPR029045 | |
| Domain | ATP_grasp_subdomain_2 | 4.97e-04 | 31 | 20 | 2 | IPR013816 | |
| Domain | UBA | 6.72e-04 | 36 | 20 | 2 | PF00627 | |
| Domain | UBA | 1.00e-03 | 44 | 20 | 2 | IPR015940 | |
| Domain | UBA | 1.14e-03 | 47 | 20 | 2 | PS50030 | |
| Domain | p53-like_TF_DNA-bd | 1.45e-03 | 53 | 20 | 2 | IPR008967 | |
| Domain | UBA-like | 2.11e-03 | 64 | 20 | 2 | IPR009060 | |
| Domain | V-set | 1.63e-02 | 184 | 20 | 2 | PF07686 | |
| Domain | ig | 1.73e-02 | 190 | 20 | 2 | PF00047 | |
| Domain | Immunoglobulin | 1.73e-02 | 190 | 20 | 2 | IPR013151 | |
| Pathway | REACTOME_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION | 2.19e-05 | 8 | 13 | 2 | M26991 | |
| Pathway | WP_BIOTIN_METABOLISM_INCLUDING_IMDS | 2.82e-05 | 9 | 13 | 2 | M40064 | |
| Pathway | REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM | 4.30e-05 | 11 | 13 | 2 | M27086 | |
| Pathway | REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM | 4.30e-05 | 11 | 13 | 2 | MM14764 | |
| Pathway | REACTOME_CARNITINE_METABOLISM | 7.10e-05 | 14 | 13 | 2 | M27098 | |
| Pathway | REACTOME_CARNITINE_METABOLISM | 7.10e-05 | 14 | 13 | 2 | MM14788 | |
| Pathway | WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY | 1.48e-04 | 20 | 13 | 2 | M39751 | |
| Pathway | WP_FATTY_ACID_BIOSYNTHESIS | 1.79e-04 | 22 | 13 | 2 | M39440 | |
| Pathway | WP_FATTY_ACID_BIOSYNTHESIS | 1.96e-04 | 23 | 13 | 2 | MM15885 | |
| Pathway | KEGG_PROPANOATE_METABOLISM | 4.08e-04 | 33 | 13 | 2 | M4086 | |
| Pathway | KEGG_PYRUVATE_METABOLISM | 6.00e-04 | 40 | 13 | 2 | M7934 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 6.62e-04 | 42 | 13 | 2 | M27172 | |
| Pathway | REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF | 1.13e-03 | 55 | 13 | 2 | M27001 | |
| Pathway | WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING | 1.68e-03 | 67 | 13 | 2 | M39630 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 1.99e-03 | 73 | 13 | 2 | MM15672 | |
| Pathway | WP_LEPTIN_SIGNALING | 2.15e-03 | 76 | 13 | 2 | M39491 | |
| Pathway | WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS | 2.75e-03 | 86 | 13 | 2 | M39375 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 3.00e-03 | 90 | 13 | 2 | M29841 | |
| Pubmed | 3.57e-08 | 12 | 20 | 3 | 21436046 | ||
| Pubmed | De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. | 3.14e-07 | 2 | 20 | 2 | 25282359 | |
| Pubmed | Brca1 expression is regulated by a bidirectional promoter that is shared by the Nbr1 gene in mouse. | 3.14e-07 | 2 | 20 | 2 | 14729266 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 27693630 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 32215608 | ||
| Pubmed | Activity and structure of human acetyl-CoA carboxylase targeted by a specific inhibitor. | 3.14e-07 | 2 | 20 | 2 | 29772612 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 29976587 | ||
| Pubmed | BRCA1 is a novel regulator of metabolic function in skeletal muscle. | 3.14e-07 | 2 | 20 | 2 | 24565757 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 24944901 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 18452305 | ||
| Pubmed | Structure and regulation of acetyl-CoA carboxylase genes of metazoa. | 3.14e-07 | 2 | 20 | 2 | 15749055 | |
| Pubmed | Hormonal regulation of acetyl-CoA carboxylase isoenzyme gene transcription. | 3.14e-07 | 2 | 20 | 2 | 20139635 | |
| Pubmed | Sequence analysis of the rat Brca1 homolog and its promoter region. | 3.14e-07 | 2 | 20 | 2 | 9892727 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 28081256 | ||
| Pubmed | Structural basis for regulation of human acetyl-CoA carboxylase. | 3.14e-07 | 2 | 20 | 2 | 29899443 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 26976583 | ||
| Pubmed | BRCA1 interacts with acetyl-CoA carboxylase through its tandem of BRCT domains. | 3.14e-07 | 2 | 20 | 2 | 12360400 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 29433631 | ||
| Pubmed | Cell cycle regulation of the BRCA1/acetyl-CoA-carboxylase complex. | 3.14e-07 | 2 | 20 | 2 | 19061860 | |
| Pubmed | Isolation of the murine Nbr1 gene adjacent to the murine Brca1 gene. | 3.14e-07 | 2 | 20 | 2 | 8975707 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 36076520 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 25001074 | ||
| Pubmed | ACCA phosphopeptide recognition by the BRCT repeats of BRCA1. | 3.14e-07 | 2 | 20 | 2 | 16698035 | |
| Pubmed | BRCA1 affects lipid synthesis through its interaction with acetyl-CoA carboxylase. | 3.14e-07 | 2 | 20 | 2 | 16326698 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 10677481 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 28290443 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 30244972 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 24338821 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 34668531 | ||
| Pubmed | AMPK-ACC signaling modulates platelet phospholipids and potentiates thrombus formation. | 9.42e-07 | 3 | 20 | 2 | 30018077 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 19846279 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 18031993 | ||
| Pubmed | The 5' end of the BRCA1 gene lies within a duplicated region of human chromosome 17q21. | 9.42e-07 | 3 | 20 | 2 | 8700509 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 28877461 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 20457939 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 36417534 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 17521700 | ||
| Pubmed | Differential activation of recombinant human acetyl-CoA carboxylases 1 and 2 by citrate. | 9.42e-07 | 3 | 20 | 2 | 18455495 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 31990961 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 27381369 | ||
| Pubmed | Hepatic de novo lipogenesis is present in liver-specific ACC1-deficient mice. | 9.42e-07 | 3 | 20 | 2 | 17210641 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 28768177 | ||
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 38447582 | ||
| Pubmed | DNA-damage-induced differentiation of leukaemic cells as an anti-cancer barrier. | 1.88e-06 | 4 | 20 | 2 | 25079327 | |
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 24185692 | ||
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 20616007 | ||
| Pubmed | Crystal structure of Spot 14, a modulator of fatty acid synthesis. | 1.88e-06 | 4 | 20 | 2 | 20952656 | |
| Pubmed | Acetyl-CoA carboxylase 1 is a suppressor of the adipocyte thermogenic program. | 3.14e-06 | 5 | 20 | 2 | 37163372 | |
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 30257991 | ||
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 32694673 | ||
| Pubmed | TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism. | 3.14e-06 | 5 | 20 | 2 | 16794074 | |
| Pubmed | Evaluation of selected binding domains for the analysis of ubiquitinated proteomes. | 6.59e-06 | 7 | 20 | 2 | 23649778 | |
| Pubmed | Functional characterization of BRCA1 gene variants by mini-gene splicing assay. | 8.78e-06 | 8 | 20 | 2 | 24667779 | |
| Pubmed | 8.78e-06 | 8 | 20 | 2 | 36001969 | ||
| Pubmed | A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. | 1.13e-05 | 9 | 20 | 2 | 7545954 | |
| Pubmed | 1.13e-05 | 9 | 20 | 2 | 21989022 | ||
| Pubmed | SIRT1 regulates Tat-induced HIV-1 transactivation through activating AMP-activated protein kinase. | 1.41e-05 | 10 | 20 | 2 | 19720090 | |
| Pubmed | 1.41e-05 | 10 | 20 | 2 | 25088364 | ||
| Pubmed | 1.72e-05 | 11 | 20 | 2 | 31816041 | ||
| Pubmed | 2.07e-05 | 12 | 20 | 2 | 21344388 | ||
| Pubmed | 2.44e-05 | 13 | 20 | 2 | 33510165 | ||
| Pubmed | 2.44e-05 | 13 | 20 | 2 | 19403657 | ||
| Pubmed | 2.85e-05 | 14 | 20 | 2 | 27974163 | ||
| Pubmed | Cdk12 Regulates Neurogenesis and Late-Arising Neuronal Migration in the Developing Cerebral Cortex. | 3.28e-05 | 15 | 20 | 2 | 27073218 | |
| Pubmed | 3.28e-05 | 15 | 20 | 2 | 34419458 | ||
| Pubmed | 3.28e-05 | 15 | 20 | 2 | 32097653 | ||
| Pubmed | 3.28e-05 | 15 | 20 | 2 | 35379995 | ||
| Pubmed | 3.75e-05 | 16 | 20 | 2 | 24639535 | ||
| Pubmed | Cep55 regulation of PI3K/Akt signaling is required for neocortical development and ciliogenesis. | 4.25e-05 | 17 | 20 | 2 | 34710087 | |
| Pubmed | Arl13b-regulated cilia activities are essential for polarized radial glial scaffold formation. | 4.78e-05 | 18 | 20 | 2 | 23817546 | |
| Pubmed | Engrailed transcription factors direct excitatory cerebellar neuron diversity and survival. | 4.78e-05 | 18 | 20 | 2 | 38912572 | |
| Pubmed | Evidence for distinct functions for human DNA repair factors hHR23A and hHR23B. | 4.78e-05 | 18 | 20 | 2 | 16712842 | |
| Pubmed | 5.34e-05 | 19 | 20 | 2 | 32985705 | ||
| Pubmed | APC sets the Wnt tone necessary for cerebral cortical progenitor development. | 5.34e-05 | 19 | 20 | 2 | 28916710 | |
| Pubmed | 6.45e-05 | 777 | 20 | 5 | 35844135 | ||
| Pubmed | BAC contig from a 3-cM region of mouse chromosome 11 surrounding Brca1. | 6.55e-05 | 21 | 20 | 2 | 11013085 | |
| Pubmed | 6.55e-05 | 21 | 20 | 2 | 19217427 | ||
| Pubmed | HDAC1 and HDAC2 Regulate Intermediate Progenitor Positioning to Safeguard Neocortical Development. | 6.55e-05 | 21 | 20 | 2 | 30709655 | |
| Pubmed | 7.21e-05 | 22 | 20 | 2 | 20965718 | ||
| Pubmed | 7.89e-05 | 23 | 20 | 2 | 14662765 | ||
| Pubmed | 8.56e-05 | 418 | 20 | 4 | 34709266 | ||
| Pubmed | 9.35e-05 | 25 | 20 | 2 | 32840212 | ||
| Pubmed | VIP blockade leads to microcephaly in mice via disruption of Mcph1-Chk1 signaling. | 1.09e-04 | 27 | 20 | 2 | 21737879 | |
| Pubmed | 1.26e-04 | 29 | 20 | 2 | 21532586 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 1.41e-04 | 1489 | 20 | 6 | 28611215 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 1.46e-04 | 180 | 20 | 3 | 35198878 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.55e-04 | 184 | 20 | 3 | 32908313 | |
| Pubmed | 1.64e-04 | 33 | 20 | 2 | 26071364 | ||
| Pubmed | 1.64e-04 | 33 | 20 | 2 | 30914320 | ||
| Pubmed | 1.74e-04 | 34 | 20 | 2 | 26378152 | ||
| Pubmed | Inceptor counteracts insulin signalling in β-cells to control glycaemia. | 1.74e-04 | 34 | 20 | 2 | 33505018 | |
| Pubmed | 2.05e-04 | 202 | 20 | 3 | 29540532 | ||
| Pubmed | 2.54e-04 | 41 | 20 | 2 | 19343720 | ||
| Pubmed | Proteomic analysis of HIV-1 Gag interacting partners using proximity-dependent biotinylation. | 2.67e-04 | 42 | 20 | 2 | 26362536 | |
| Pubmed | Functional dissection of Rab GTPases involved in primary cilium formation. | 2.80e-04 | 43 | 20 | 2 | 17646400 | |
| Pubmed | 2.84e-04 | 226 | 20 | 3 | 31452512 | ||
| Pubmed | 3.48e-04 | 242 | 20 | 3 | 34011540 | ||
| Pubmed | 3.50e-04 | 604 | 20 | 4 | 38803224 | ||
| Pubmed | 3.59e-04 | 608 | 20 | 4 | 16713569 | ||
| Pubmed | Crosstalk between Lys63- and Lys11-polyubiquitin signaling at DNA damage sites is driven by Cezanne. | 3.79e-04 | 50 | 20 | 2 | 31699778 | |
| Cytoband | 17q21 | 3.47e-04 | 63 | 20 | 2 | 17q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q22 | 2.86e-03 | 183 | 20 | 2 | chr16q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q24 | 1.39e-02 | 415 | 20 | 2 | chr12q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 1.78e-02 | 473 | 20 | 2 | chr17q21 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 8.92e-03 | 163 | 16 | 2 | 590 | |
| ToppCell | severe_COVID-19-B_cell|World / disease group, cell group and cell class (v2) | 3.44e-05 | 143 | 20 | 3 | 28b0e168126a9fe60541dc12bfab385b7a0a2342 | |
| ToppCell | severe_COVID-19-B_cell|severe_COVID-19 / disease group, cell group and cell class (v2) | 3.52e-05 | 144 | 20 | 3 | c7f696e55e2d959c58ec32640c71ef86ee25203c | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Col27a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.30e-05 | 154 | 20 | 3 | d22902d2922784583f7016453768ed05b14b965e | |
| ToppCell | COVID-CD4-CD4_Treg|COVID / Condition, Cell_class and T cell subcluster | 4.72e-05 | 159 | 20 | 3 | 037cd97c41eb2f91fd3f69bbb3ffdfd6c0158410 | |
| ToppCell | 10x5'-Liver-Lymphocytic_Invariant-Inducer-like-ILC3|Liver / Manually curated celltypes from each tissue | 5.09e-05 | 163 | 20 | 3 | 7f61483eeb1fde21843c6391468e13cb0cc2a89f | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.61e-05 | 178 | 20 | 3 | 8b939659f713eea50a1a6e28b571f680ca0b4c12 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.17e-05 | 183 | 20 | 3 | f142b320023eef00b48d4820c46214c9794d37e7 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.41e-05 | 185 | 20 | 3 | e06a784a297f357f3f8e761c24fa70722048ab42 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.53e-05 | 186 | 20 | 3 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.53e-05 | 186 | 20 | 3 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.27e-05 | 192 | 20 | 3 | c7bcebcb88a25b2c97d798120efa9d5958e7f798 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-NK|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.27e-05 | 192 | 20 | 3 | 930319cbd82b9e54864147ffcdc8bd0ea7b937be | |
| Computational | Steroid hormone receptors and binding proteins. | 2.50e-04 | 26 | 10 | 2 | MODULE_404 | |
| Drug | 6,8-diallyl 5,7-dihydroxy 2-(2-allyl 3-hydroxy 4-methoxyphenyl)1-H benzo(b)pyran-4-one | 1.10e-05 | 6 | 20 | 2 | ctd:C438505 | |
| Drug | Finasteride [98319-26-7]; Up 200; 10.8uM; PC3; HT_HG-U133A | 2.27e-05 | 195 | 20 | 4 | 4300_UP | |
| Drug | Biotin | 2.63e-05 | 9 | 20 | 2 | DB00121 | |
| Drug | isosteviol | 4.81e-05 | 12 | 20 | 2 | ctd:C515747 | |
| Disease | muscular disease (implicated_via_orthology) | 4.36e-06 | 5 | 20 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | breast carcinoma (is_marker_for) | 1.19e-05 | 66 | 20 | 3 | DOID:3459 (is_marker_for) | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.10e-04 | 139 | 20 | 3 | DOID:3908 (is_implicated_in) | |
| Disease | fatty liver disease (implicated_via_orthology) | 2.01e-04 | 31 | 20 | 2 | DOID:9452 (implicated_via_orthology) | |
| Disease | breast cancer (is_marker_for) | 2.56e-04 | 185 | 20 | 3 | DOID:1612 (is_marker_for) | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 4.25e-04 | 45 | 20 | 2 | DOID:3748 (is_implicated_in) | |
| Disease | Prostatic Neoplasms | 6.98e-04 | 616 | 20 | 4 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 6.98e-04 | 616 | 20 | 4 | C0376358 | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 8.85e-04 | 65 | 20 | 2 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | prostate cancer (is_implicated_in) | 2.83e-03 | 117 | 20 | 2 | DOID:10283 (is_implicated_in) | |
| Disease | tea consumption measurement | 3.42e-03 | 129 | 20 | 2 | EFO_0010091 | |
| Disease | stomach cancer (is_marker_for) | 4.13e-03 | 142 | 20 | 2 | DOID:10534 (is_marker_for) | |
| Disease | colorectal cancer (is_marker_for) | 5.02e-03 | 157 | 20 | 2 | DOID:9256 (is_marker_for) | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 5.79e-03 | 169 | 20 | 2 | DOID:3908 (is_marker_for) | |
| Disease | heart failure | 6.90e-03 | 185 | 20 | 2 | EFO_0003144 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 8.02e-03 | 200 | 20 | 2 | EFO_0004611, EFO_0020945 | |
| Disease | post-traumatic stress disorder | 8.17e-03 | 202 | 20 | 2 | EFO_0001358 | |
| Disease | Obesity | 8.40e-03 | 205 | 20 | 2 | C0028754 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NNQLGGIQIMHNNGV | 1866 | Q13085 | |
| QGQVNHNGQKNNEFG | 301 | Q3SXY8 | |
| LNGEQAQNAIQMFHQ | 111 | Q9HCJ3 | |
| QINKMRNGQHFCDVQ | 26 | Q9Y573 | |
| SNNQLGGVQIMHYNG | 1976 | O00763 | |
| QQNNIKDQGNPQFEM | 956 | Q86YR7 | |
| LFHNTAGGTMNQLQN | 1421 | O94916 | |
| QNGQVMNITNSGHEN | 541 | P38398 | |
| MQNNANGNLIQDDIG | 2826 | Q0VDD8 | |
| LTNNKGASNNNGQMV | 311 | Q16650 | |
| AVKQGNQLQMQVHEG | 71 | Q14596 | |
| VKQCHEQNMFGNIVN | 101 | Q8N8J6 | |
| EQNMFGNIVNQNKGH | 106 | Q8N8J6 | |
| FHDKNGMQIDQNFNN | 576 | Q8N2E2 | |
| GHQQFIQQMLQALAG | 521 | Q9UMX0 | |
| LVNGNIEQMGNGFQD | 506 | Q8N0Z9 | |
| MQQNSADKANFNQGL | 286 | Q9BR11 | |
| QNTMHNIRGNKQAQG | 216 | Q9BYX2 | |
| QSDKHLNNMQNLQNG | 746 | Q15911 | |
| QQQHQQQGSMAGLSH | 3861 | O14686 | |
| EGIKQAMNHFVQENG | 476 | Q96NY8 |